It has been shown that the antibody does not disappear for at least half a year if you get the Corona 19 vaccine from U.S. biotechnology company Modena.
An analysis of 33 healthy adults who participated in a phase 1 clinical trial of a corona 19 vaccine by US biotechnology company Modena showed that the antibody persisted for at least 6 months after two vaccinations, Bloomberg and AP reported on the 6th (local time). .
In addition to Modena, the results of this study, which were jointly participated by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) and Emery University, were published in the New England Journal of Medicine, an international academic journal.
In a short study letter published in the journal, the researchers said, “Our data shows the persistence of antibodies,” and “thus, we support the use of this vaccine to counter the COVID-19 pandemic.”
These contents are similar to the previously announced test results of the Pfizer-Bioentech vaccine.
Pfizer and Bioentech announced on the 1st that an analysis of 46,307 participants in the phase 3 trial showed that they maintained a high prevention effect of 91.3% even after 6 months of vaccination.
However, Bloomberg said in response to Modena’s announcement that a small number of Phase 1 test participants’ blood samples were analyzed in the laboratory, so it could not directly measure how long the vaccine’s prophylaxis would last in a real environment.
On the other hand, the New England Journal of Medicine on that day also published a report showing that, as a result of a study of 50 people who had been vaccinated with a Chinese-developed synopam or synovac vaccine, the efficacy against the South African mutant virus was completely or partially lost. The AP said.
(Photo = Getty Image Korea)